Stay updated on Nivolumab in Metastatic Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page's revision tag changed to Revision: v3.5.3, replacing Revision: v3.5.2, indicating a metadata/update version for the study record. This appears to be a minor update to the page's revision history rather than content changes.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site revision label was updated from Revision: v3.5.0 to Revision: v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedUpdated the Italy location entry from Napoli, Italy, 80131 to Naples, Italy, 80131 and updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check91 days agoChange DetectedAdded a site-wide funding status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in Metastatic Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.